FDA Drugs (New Approvals & NDA)Original article
RISE to the Challenge: Statistical Considerations for Rare Disease Clinical Investigations - 09/29/2026
ConferenceNeutral
AI Analysis
Summary
Duke Margolis and the FDA Rare Disease Innovation Hub will co-host a public workshop on September 29, 2026, to discuss statistical considerations in the design, conduct, and analysis of clinical investigations for rare disease medical products.
Importance:2/10
Sentiment:
0.00
rare diseaseclinical trial designstatistical considerationsworkshopFDA
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 14, 2026 3:50 PM